http://orcid.org/0000-0001-8321-778X
Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ruiqi Zhang & Ivan Fan-Ngai Hung. (2021) Approaches in broadening the neutralizing antibody response of the influenza vaccine. Expert Review of Vaccines 20:12, pages 1539-1547.
Read now
Read now
Irina Isakova-Sivak, Ekaterina Stepanova, Daria Mezhenskaya, Victoria Matyushenko, Polina Prokopenko, Ivan Sychev, Pei-Fong Wong & Larisa Rudenko. (2021) Influenza vaccine: progress in a vaccine that elicits a broad immune response. Expert Review of Vaccines 20:9, pages 1097-1112.
Read now
Read now
Irina Isakova-Sivak, Elena Grigorieva & Larisa Rudenko. (2020) Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines. Expert Review of Vaccines 19:1, pages 43-55.
Read now
Read now
Asim Biswas, Alok K. Chakrabarti & Shanta Dutta. (2020) Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines. International Reviews of Immunology 39:1, pages 21-36.
Read now
Read now
Articles from other publishers (35)
Weiyang Sun, Jiaqi Xu, Zhenfei Wang, Dongxu Li, Yue Sun, Menghan Zhu, Xiawei Liu, Yuanguo Li, Fangxu Li, Tiecheng Wang, Na Feng, Zhendong Guo, Xianzhu Xia & Yuwei Gao. (2023) Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets. Journal of Virology 97:11.
Crossref
Crossref
Alexandra Rak, Irina Isakova-Sivak & Larisa Rudenko. (2023) Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines. Vaccines 11:12, pages 1747.
Crossref
Crossref
Marjan Assefi, Mehrnaz Ataeinaeini, Ahmad Nazari, Arsalan Gholipour, Jacinto Joaquin Vertiz-Osores, Kriss Melody Calla-Vásquez, Bashar Zuhair Talib Al-Naqeeb, Kadhim Hussein Jassim, Hesam Ghafouri Kalajahi, Saman Yasamineh & Mehdi Dadashpour. (2023) A state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system. Journal of Drug Delivery Science and Technology 86, pages 104623.
Crossref
Crossref
Hyeong-Jun Park, Yoo-Jin Bang, Sung Pil Kwon, Woori Kwak, Sang-In Park, Gahyun Roh, Seo-Hyeon Bae, Jae-Yong Kim, Hye Won Kwak, Yongkwan Kim, Soyeon Yoo, Daegeun Kim, Gyochang Keum, Eun-Kyoung Bang, So-Hee Hong & Jae-Hwan Nam. (2023) Analyzing immune responses to varied mRNA and protein vaccine sequences. npj Vaccines 8:1.
Crossref
Crossref
Piyush Dey, Akanksha Ahuja, Jaishal Panwar, Poonam Choudhary, Shital Rani, Mandeep Kaur, Akanksha Sharma, Jatinder Kaur, Ashok Kumar Yadav, Vikas Sood, Adukamparai R. Suresh Babu, Sanjay K. Bhadada, Gurpal Singh & Ravi Pratap Barnwal. (2023) Immune Control of Avian Influenza Virus Infection and Its Vaccine Development. Vaccines 11:3, pages 593.
Crossref
Crossref
Polina Prokopenko, Victoria Matyushenko, Alexandra Rak, Ekaterina Stepanova, Anna Chistyakova, Arina Goshina, Igor Kudryavtsev, Larisa Rudenko & Irina Isakova-Sivak. (2023) Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein. Vaccines 11:3, pages 501.
Crossref
Crossref
Sergey Petrovich Krechetov, Valentina Valentinovna Vtorushina, Evgenia Vladimirovna Inviyaeva, Elena Aleksandrovna Gorodnova, Svetlana Vladimirovna Kolesnik, Dmitry Anatolievich Kudlay, Pavel Igorevich Borovikov, Liubov Valentinovna Krechetova, Nataliya Vitalievna Dolgushina & Gennady Tikhonovich Sukhikh. (2023) T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac. International Journal of Molecular Sciences 24:3, pages 1930.
Crossref
Crossref
Matheswaran Kandasamy, Uzi Gileadi, Pramila Rijal, Tiong Kit Tan, Lian N Lee, Jili Chen, Gennaro Prota, Paul Klenerman, Alain Townsend & Vincenzo Cerundolo. (2023) Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors. eLife 12.
Crossref
Crossref
Sumedha Bagga, Anand Krishnan & Lalit Dar. (2023) Revisiting live attenuated influenza vaccine efficacy among children in developing countries. Vaccine 41:5, pages 1009-1017.
Crossref
Crossref
Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels & Isabel Leroux-Roels. (2022) The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Frontiers in Immunology 13.
Crossref
Crossref
Aitor Nogales, Marta L. DeDiego & Luis Martínez-Sobrido. (2022) Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Irina Isakova-Sivak, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria Mezhenskaya, Ekaterina Bazhenova, Elena Krutikova, Tatiana Kotomina, Polina Prokopenko, Bogdan Neterebskii, Aleksandr Doronin, Elena Vinogradova, Kirill Yakovlev, Konstantin Sivak & Larisa Rudenko. (2022) Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector. Vaccines 10:7, pages 1142.
Crossref
Crossref
Aitor Nogales, John Steel, Wen-Chun Liu, Anice C. Lowen, Laura Rodriguez, Kevin Chiem, Andrew Cox, Adolfo García-Sastre, Randy A. Albrecht, Stephen Dewhurst & Luis Martínez-Sobrido. (2022) Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine. Microbiology Spectrum 10:3.
Crossref
Crossref
Weiyang Sun, Zhenfei Wang, Yue Sun, Dongxu Li, Menghan Zhu, Menglin Zhao, Yutian Wang, Jiaqi Xu, Yunyi Kong, Yuanguo Li, Na Feng, Tiecheng Wang, Yongkun Zhao, Songtao Yang, Yuwei Gao & Xianzhu Xia. (2021) Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model. Viruses 13:12, pages 2420.
Crossref
Crossref
David R. McIlwain, Han Chen, Zainab Rahil, Neda Hajiakhoond Bidoki, Sizun Jiang, Zach Bjornson, Nikita S. Kolhatkar, C. Josefina Martinez, Brice Gaudillière, Julien Hedou, Nilanjan Mukherjee, Christian M. Schürch, Angelica Trejo, Melton Affrime, Bonnie Bock, Kenneth Kim, David Liebowitz, Nima Aghaeepour, Sean N. Tucker & Garry P. Nolan. (2021) Human influenza virus challenge identifies cellular correlates of protection for oral vaccination. Cell Host & Microbe 29:12, pages 1828-1837.e5.
Crossref
Crossref
Abira Paramsothy, Sarah Lartey Jalloh, Richard A. Davies, Anne‐Berit Guttormsen, Rebecca J. Cox & Kristin G.‐I. Mohn. (2021) Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients. Scandinavian Journal of Immunology 94:2.
Crossref
Crossref
Daria Mezhenskaya, Irina Isakova-Sivak, Victoria Matyushenko, Svetlana Donina, Andrey Rekstin, Konstantin Sivak, Kirill Yakovlev, Anastasia Katelnikova, Kirill Kryshen, Valery Makarov & Larisa Rudenko. (2021) Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge. Viruses 13:7, pages 1280.
Crossref
Crossref
Hanna Turlewicz-Podbielska, Anna Kuriga, Rafał Niemyjski, Grzegorz Tarasiuk & Małgorzata Pomorska-Mól. (2021) African Swine Fever Virus as a Difficult Opponent in the Fight for a Vaccine—Current Data. Viruses 13:7, pages 1212.
Crossref
Crossref
Laura Franza & Rossella Cianci. (2021) Pollution, Inflammation, and Vaccines: A Complex Crosstalk. International Journal of Environmental Research and Public Health 18:12, pages 6330.
Crossref
Crossref
Mario Cortese, Amy C. Sherman, Nadine G. Rouphael & Bali Pulendran. (2021) Systems Biological Analysis of Immune Response to Influenza Vaccination. Cold Spring Harbor Perspectives in Medicine 11:6, pages a038596.
Crossref
Crossref
Thomas Parr, Anjali Bhat, Peter Zeidman, Aimee Goel, Alexander J. Billig, Rosalyn Moran & Karl J. Friston. (2021) Dynamic causal modelling of immune heterogeneity. Scientific Reports 11:1.
Crossref
Crossref
Carmine D’Amico, Flavia Fontana, Ruoyu Cheng & Hélder A. Santos. (2021) Development of vaccine formulations: past, present, and future. Drug Delivery and Translational Research 11:2, pages 353-372.
Crossref
Crossref
Laia Bosch-Camós, Elisabeth López & Fernando Rodriguez. (2020) African swine fever vaccines: a promising work still in progress. Porcine Health Management 6:1.
Crossref
Crossref
Tatiana Kotomina, Irina Isakova-Sivak, Ki-Hye Kim, Bo Ryoung Park, Yu-Jin Jung, Youri Lee, Daria Mezhenskaya, Victoria Matyushenko, Sang-Moo Kang & Larisa Rudenko. (2020) Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes. Vaccines 8:4, pages 648.
Crossref
Crossref
Yaron Drori, Jasmine Jacob-Hirsch, Rakefet Pando, Aharona Glatman-Freedman, Nehemya Friedman, Ella Mendelson & Michal Mandelboim. (2020) Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins. Viruses 12:10, pages 1171.
Crossref
Crossref
Koen van de Ven, Femke de Heij, Harry van Dijken, José A. Ferreira & Jørgen de Jonge. (2020) Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets. Communications Biology 3:1.
Crossref
Crossref
Victoria Matyushenko, Tatiana Kotomina, Igor Kudryavtsev, Daria Mezhenskaya, Polina Prokopenko, Anastasia Matushkina, Konstantin Sivak, Arman Muzhikyan, Larisa Rudenko & Irina Isakova-Sivak. (2020) Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses. Antiviral Research 182, pages 104864.
Crossref
Crossref
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Asisa Volz, Gerd Sutter & Guus F. Rimmelzwaan. (2020) Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines 8:3, pages 451.
Crossref
Crossref
Ekaterina Stepanova, Victoria Matyushenko, Larisa Rudenko & Irina Isakova-Sivak. (2020) Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus. Pathogens 9:6, pages 481.
Crossref
Crossref
Irina Isakova-Sivak, Victoria Matyushenko, Ekaterina Stepanova, Anastasia Matushkina, Tatiana Kotomina, Daria Mezhenskaya, Polina Prokopenko, Igor Kudryavtsev, Pavel Kopeykin, Konstantin Sivak & Larisa Rudenko. (2020) Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T Cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T Cell Responses and Protect Mice against both Infections. Vaccines 8:2, pages 196.
Crossref
Crossref
Caitlin Ritz, Wenzhao MengNatasha L. StanleyMiren L. Baroja, Chong Xu, Patrick Yan, Alexander C. Huang, Ryan HauslerPeter NicholasJian-Meng FanDavid LiebermanBeatriz M. Carreno, Eline T. Luning Prak, Timothy S. Olson & Daria V. Babushok. (2020) Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes. Blood Advances 4:7, pages 1378-1382.
Crossref
Crossref
Stanley A. Plotkin. (2020) Updates on immunologic correlates of vaccine-induced protection. Vaccine 38:9, pages 2250-2257.
Crossref
Crossref
Graham Pawelec & Janet McElhaney. (2020) Recent advances in influenza vaccines. F1000Research 9, pages 305.
Crossref
Crossref
Weina Sun, Allen Zheng, Robert Miller, Florian Krammer & Peter Palese. (2019) An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains. Vaccines 7:3, pages 117.
Crossref
Crossref
Tatiana Kotomina, Irina Isakova-Sivak, Victoria Matyushenko, Ki-Hye Kim, Youri Lee, Yu-Jin Jung, Sang-Moo Kang & Larisa Rudenko. (2019) Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. Antiviral Research 168, pages 9-17.
Crossref
Crossref